Filetype
TRIAD står för Three (TRI) Autoimmune Diseases. De sjukdomar som undersöks i TRIAD-studien är autoimmun (typ 1) diabetes, celiaki (glutenintolerans) och sköldkörtelsjukdom.Syftet med TRIAD-studien är att hitta barn som redan har någon av dessa sjukdomar utan att veta om det eller som har ökad risk att utveckla någon av sjukdomarna i framtiden. Detta görs genom att undersöka förekomsten av så kalla
https://www.teddy.lu.se/alla-studier-i-cap/nya-pagaende-studier-i-cap/triad - 2026-01-03
TEDDY-forskningspersoner hjälper till att upptäcka T mördar lymfocyter som attackerar betaceller. Vita blodkropparna gör olika saker. B-celler gör antikroppar. T-hjälparceller lär ut hur infektioner ska tas om hand. Renhållningsceller äter sjuka och skadade celler. T-mördarceller dödar virusinfekterade celler. Tyvärr också betaceller vid autoimmun (typ 1) diabetes. Det har inte varit möjligt tidi
https://www.teddy.lu.se/alla-studier-i-cap/avslutade-studier-i-cap/cd8-projekt - 2026-01-03
Komplementfaktorer tillhör det medfödda immunförsvaret. Det medfödda immunförsvaret påverkar hur vi hanterar bakterie- och virusangrepp. Komplementfaktorer har även samband med det adaptiva immunsystemet där olika antikroppar är involverade. Komplementfaktorer interagerar även med koagulationssystemet (dvs det system som styr blodets förmåga att levra sig).”Single nucleotide polymorphism” (SNP) är
TEDDY studien samlar in information 40–50 gånger fram till 15 års ålder beroende på om forskningspersonen har autoantikroppar eller ej.Det är information av olika typ som samlas in. Vid varje besök analyseras sju olika autoantikroppar, som är biomarkörer för autoimmun (typ 1) diabetes, celiaki och sköldkörtelinflammation. IAA, GADA, IA-2A och ZnT8A är biomarkörer för autoimmun (typ 1) diabetes. tT
National Annika Karlsson - Department of Laboratory Medicine, Karolinska Institutet Fredrik Månsson - Department of Translational Medicine, Lund University Gülsen Özkaya Sahin - Region Skåne, Department of Laboratory Medicine, Section of Clinical Microbiology; Department of Translational Medicine, Lund University Hans Norrgren - Division of Infection Medicine, Lund University Joakim Esbjörnsso
https://www.virology.lu.se/hiv-host-interactions/collaborators - 2026-01-03
Marianne JanssonAvd Medicinsk MikrobiologiInst laboratoriemedicinBMC B13Sölvegatan 19121 84 LundPhone +46-46-222 1770Email: Marianne [dot] Jansson [at] med [dot] lu [dot] se
https://www.virology.lu.se/hiv-host-interactions/contact - 2026-01-03
Read about Stefan in the Research Portal Principal Investigator
https://www.virology.lu.se/molecular-virology/stefan-schwartz - 2026-01-03
Stefan Schwartz Stefan Schwartz_LUCRISStefan Schwartz_PubMed
https://www.virology.lu.se/molecular-virology/publications - 2026-01-03
Ola Forslund, Clinical Microbiology, Region Skåne, SwedenTroy Chengjun Wu, Dalianj University, China
https://www.virology.lu.se/molecular-virology/collaborators - 2026-01-03
Stefan Schwartz - Lund University
https://www.virology.lu.se/molecular-virology/contact - 2026-01-03
Joakim Esbjörnsson, PhD Associate Professor in Virology Senior Lecturer in Medical Microbiology Head of Systems Virology Group Department of Translational Medicine Faculty of Medicine Lund University Postal address: Lund University BMC, B13 221 84 Lund Sweden Phone: +46 46 22 20119, Office email: joakim [dot] esbjornsson [at] med [dot] lu [dot] se (joakim[dot]esbjornsson[at]med[dot]lu[dot]se) Ho
https://www.virology.lu.se/systems-virology/contact - 2026-01-03
Joakim Esbjörnsson Associate Professor Ph.D. Virology Read about Joakim in the Research Portal Joakim's publications" The overarching aim of my research is to understand the key mechanisms of HIV transmission and the rate of disease pathogenesis. I am particularly interested in the virus-host interactions that take place when HIV establishes infection, and how HIV-2 can be used as a mode
https://www.virology.lu.se/systems-virology/systems-virology-team - 2026-01-03
Executive board Joakim Esbjörnsson, coordinatorMarianne Jansson, vice coordinatorPatrik Medstrand, vice coordinatorOla Forslund, vice coordinator
https://www.virology.lu.se/our-organisation - 2026-01-03
The focus of the clinical virology team is to develop and further improve diagnostic tools for detection and quantification of viral infections, including next-generation sequencing approaches in the field of “pandemic preparedness”. Our current work in the field involves many collaborators, the establishment of biobanks and the use of clinical and environmental specimens in our investigations. Du
https://www.virology.lu.se/clinical-virology - 2026-01-03
Vision We want to create a regionally, nationally and internationally well-known center for translational virus research at the highest level where experimental and clinical research meet in synergy. New Virus Centre Pandemics and alertness The Covid-19 pandemic has clearly demonstrated how fast viruses can become a significant threat to global health. Through national and international collabor
https://www.virology.lu.se/virology - 2026-01-03
Human papillomavirus (HPV) infections cause 500.000 cases of cervical cancer each year in the world (400 cases in Sweden), and 250.000 deaths (120 cases in Sweden). HPV16 is the most common cancer-associated HPV type. The majority of all HPV16 infections is cleared by the host but a fraction persists that may cause cancer. The full life cycle of HPV16 requires cell proliferation at the early stage
https://www.virology.lu.se/molecular-virology - 2026-01-03
Gemma Atkinson, Lund University Vasili Hauryliuk, Lund University
https://www.virology.lu.se/affiliated - 2026-01-03
Associate Professor Joakim is an Associate professor at the Department of Translational Medicine, Faculty of Medicine PRINCIPAL INVESTIGATOR
https://www.virology.lu.se/pi-joakim-esbjornsson-phd - 2026-01-03
Principal Investigator, Associate Professor in Virology “What would be easy turned out to be difficult. That is one way of summarising over 30 years of efforts to find a vaccine or a cure for HIV, the virus that causes the disease AIDS. It is this scientific challenge that triggers the researcher Joakim Esbjörnsson.” From “Forskarnas Nyheter”(2017) Joakim Esbjörnsson is an Associate senior lecture
https://www.virology.lu.se/systems-virology/joakim-esbjornsson-phd - 2026-01-03
The Covid-19 pandemic has clearly demonstrated how fast viruses can become a significant threat to global health. Through national and international collaboration, we can improve our readiness for future virus outbreaks.Pandemics and alertness | Lund UniversityLinkedIn_Pandemics_and alertness
https://www.virology.lu.se/pandemics-and-alertness - 2026-01-03
